Sherbrooke Park Advisers LLC Foghorn Therapeutics Inc. Transaction History
Sherbrooke Park Advisers LLC
- $215 Billion
- Q1 2025
A detailed history of Sherbrooke Park Advisers LLC transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 13,075 shares of FHTX stock, worth $53,346. This represents 0.02% of its overall portfolio holdings.
Number of Shares
13,075
Previous 15,617
16.28%
Holding current value
$53,346
Previous $73.7 Million
35.26%
% of portfolio
0.02%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding FHTX
# of Institutions
89Shares Held
36.7MCall Options Held
100Put Options Held
0-
Flagship Pioneering Inc. Cambridge, MA12.7MShares$51.7 Million19.62% of portfolio
-
Bvf Inc San Francisco, CA5.3MShares$21.6 Million0.85% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.26MShares$13.3 Million0.3% of portfolio
-
Raymond James & Associates St Petersburg, FL2.3MShares$9.37 Million0.01% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL2.22MShares$9.05 Million0.0% of portfolio
About Foghorn Therapeutics Inc.
- Ticker FHTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,637,400
- Market Cap $170M
- Description
- Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...